Moreover, MYH10 expression was associated with those factors, such as FIGO (International Federation of Gynecology and Obstetrics) stage (p < 0.0001), intraperitoneal metastasis (p < 0.0001), and intestinal metastasis (p = 0.0281), Ascites with tumor cells (+) (p = 0.0002), and the association between MYH10 and clinical parameters was listed in Table 1. Here, MYH10 is linked to neoplasm.